Management of primary antibody deficiency with replacement therapy: summary of guidelines

Immunol Allergy Clin North Am. 2008 Nov;28(4):875-6, x. doi: 10.1016/j.iac.2008.07.003.

Authors

Chaim M Roifman¹, Melvin Berger, Luigi D Notarangelo

Affiliation

¹ Division of Immunology and Allergy, Department of Paediatrics, The Research Institute of Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8. croifman@sickkids.ca

PMID: 18940580
DOI: 10.1016/j.iac.2008.07.003

Abstract

This article summarizes the guidelines for using replacement therapy in the management of patients who have primary antibody deficiency.

Publication types

Practice Guideline

MeSH terms

Drug Administration Routes
Guidelines as Topic*
Humans
Immunization, Passive / adverse effects
Immunization, Passive / economics
Immunization, Passive / methods*
Immunologic Deficiency Syndromes / diagnosis
Immunologic Deficiency Syndromes / immunology
Immunologic Deficiency Syndromes / therapy*
Immunologic Tests
Respiratory Function Tests